Report Detail
Global Injectable Drugs Market Insights, Forecast to 2025
- RnM3430330 |
- 20 May, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body.
Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such as morphine or diacetylmorphine/heroin; roughly two-thirds of which is destroyed in the liver when consumed orally) than oral ingestion would, meaning users get a stronger (yet shorter-acting) effect from the same amount of the drug.
The global Injectable Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Injectable Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Injectable Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Injectable Drugs in these regions.
This research report categorizes the global Injectable Drugs market by top players/brands, region, type and end user. This report also studies the global Injectable Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Sanofi
Market size by Product
Biologics
Small molecules
Market size by End User
Auto-immune diseases
Hormonal Disorders
Orphan Diseases
Oncology
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Injectable Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Injectable Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Injectable Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Injectable Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Injectable Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Injectable Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Injectable Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Injectable Drugs Market Size Growth Rate by Product
- 1.4.2 Biologics
- 1.4.3 Small molecules
- 1.5 Market by End User
- 1.5.1 Global Injectable Drugs Market Size Growth Rate by End User
- 1.5.2 Auto-immune diseases
- 1.5.3 Hormonal Disorders
- 1.5.4 Orphan Diseases
- 1.5.5 Oncology
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Injectable Drugs Market Size
- 2.1.1 Global Injectable Drugs Revenue 2014-2025
- 2.1.2 Global Injectable Drugs Sales 2014-2025
- 2.2 Injectable Drugs Growth Rate by Regions
- 2.2.1 Global Injectable Drugs Sales by Regions
- 2.2.2 Global Injectable Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Injectable Drugs Sales by Manufacturers
- 3.1.1 Injectable Drugs Sales by Manufacturers
- 3.1.2 Injectable Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Injectable Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Injectable Drugs Revenue by Manufacturers
- 3.2.1 Injectable Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Injectable Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Injectable Drugs Price by Manufacturers
- 3.4 Injectable Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Injectable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Injectable Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Injectable Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Injectable Drugs Sales by Product
- 4.2 Global Injectable Drugs Revenue by Product
- 4.3 Injectable Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Injectable Drugs Breakdown Data by End User
6 North America
- 6.1 North America Injectable Drugs by Countries
- 6.1.1 North America Injectable Drugs Sales by Countries
- 6.1.2 North America Injectable Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Injectable Drugs by Product
- 6.3 North America Injectable Drugs by End User
7 Europe
- 7.1 Europe Injectable Drugs by Countries
- 7.1.1 Europe Injectable Drugs Sales by Countries
- 7.1.2 Europe Injectable Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Injectable Drugs by Product
- 7.3 Europe Injectable Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Injectable Drugs by Countries
- 8.1.1 Asia Pacific Injectable Drugs Sales by Countries
- 8.1.2 Asia Pacific Injectable Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Injectable Drugs by Product
- 8.3 Asia Pacific Injectable Drugs by End User
9 Central & South America
- 9.1 Central & South America Injectable Drugs by Countries
- 9.1.1 Central & South America Injectable Drugs Sales by Countries
- 9.1.2 Central & South America Injectable Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Injectable Drugs by Product
- 9.3 Central & South America Injectable Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Injectable Drugs by Countries
- 10.1.1 Middle East and Africa Injectable Drugs Sales by Countries
- 10.1.2 Middle East and Africa Injectable Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Injectable Drugs by Product
- 10.3 Middle East and Africa Injectable Drugs by End User
11 Company Profiles
- 11.1 AbbVie
- 11.1.1 AbbVie Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AbbVie Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AbbVie Injectable Drugs Products Offered
- 11.1.5 AbbVie Recent Development
- 11.2 F. Hoffmann-La Roche
- 11.2.1 F. Hoffmann-La Roche Company Details
- 11.2.2 Company Business Overview
- 11.2.3 F. Hoffmann-La Roche Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 F. Hoffmann-La Roche Injectable Drugs Products Offered
- 11.2.5 F. Hoffmann-La Roche Recent Development
- 11.3 GlaxoSmithKline
- 11.3.1 GlaxoSmithKline Company Details
- 11.3.2 Company Business Overview
- 11.3.3 GlaxoSmithKline Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 GlaxoSmithKline Injectable Drugs Products Offered
- 11.3.5 GlaxoSmithKline Recent Development
- 11.4 Sanofi
- 11.4.1 Sanofi Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sanofi Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sanofi Injectable Drugs Products Offered
- 11.4.5 Sanofi Recent Development
12 Future Forecast
- 12.1 Injectable Drugs Market Forecast by Regions
- 12.1.1 Global Injectable Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Injectable Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Injectable Drugs Market Forecast by Product
- 12.2.1 Global Injectable Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Injectable Drugs Revenue Forecast by Product 2019-2025
- 12.3 Injectable Drugs Market Forecast by End User
- 12.4 North America Injectable Drugs Forecast
- 12.5 Europe Injectable Drugs Forecast
- 12.6 Asia Pacific Injectable Drugs Forecast
- 12.7 Central & South America Injectable Drugs Forecast
- 12.8 Middle East and Africa Injectable Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Injectable Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Injectable Drugs . Industry analysis & Market Report on Injectable Drugs is a syndicated market report, published as Global Injectable Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Injectable Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
